CD1--a new paradigm for antigen presentation and T cell activation

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• The CD1 family of molecules, identified in the late 1970s, had an undetermined function for over a decade.
• Major histocompatibility complex (MHC) class I and class II molecules present peptide antigens to T cells.
• A gap existed in understanding the presentation of non-peptide antigens in immune responses.

Purpose of the Study:

• To elucidate the function of CD1 molecules in antigen presentation.
• To differentiate CD1-mediated antigen presentation from MHC-restricted pathways.
• To investigate the role of CD1 in host defense against microbial infections, particularly mycobacteria.

Main Methods:

• Characterization of CD1 molecule structure and antigen-binding capabilities.
• Analysis of CD1 trafficking pathways within cells, including endosomal compartments.
• Investigation of T cell activation by CD1-lipid antigen complexes.
• Assessment of T cell responses, including cytokine secretion and cytotoxic activity, against infected cells.

Main Results:

• CD1 molecules present lipid and glycolipid antigens, unlike MHC molecules which present peptides.
• CD1 molecules utilize a unique cytoplasmic signal for trafficking to endosomal compartments to sample antigens.
• CD1-restricted T cells are activated by mycobacteria-derived lipid antigens.
• Activated CD1-restricted T cells kill infected cells and secrete interferon-gamma, suggesting a role in clearing mycobacterial infections.

Conclusions:

• CD1 molecules represent a novel class of antigen-presenting molecules distinct from MHC.
• The CD1 pathway facilitates the presentation of nonpeptide antigens, expanding our understanding of immunoregulation.
• CD1-mediated T cell responses play a significant role in host defense against mycobacterial infections.
• The identification of this MHC-independent pathway offers new therapeutic targets for infectious diseases.